“…Being able to analyse such ancestral data from both genomic and transcriptomic point of view, using a phylomics approach, will lead to a more biologically informative data. The field of phenomics, transcriptomics, genomics, methylomics, phylomics, interactomics and so on (Harris et al, 2003;Drysdale and Crosby, 2005;Kahraman et al, 2005) has opened avenues and can increase our ability to characterize changes in different cancers through 'multi-omics' analysis. The integration of these multiple approaches will be far more efficient and effective in identifying, refining and validating cancer genes, their participating pathways and biological impact on the cancer phenotypes (Chin et al, 2006;Yao et al, 2006).…”